The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

9 pts

Opinion on  Allergan Inc. (AGN)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Cosmetic & Reconstructive Medicine: An Industry Profile

Oct 12, 2008 02:47 PM GMT
Mikerun
Return Risk
+1.04% LOW
Principal

Cosmetic & Reconstructive Medicine : An Industry Profile

Cosmetic & Reconstructive Medicine Index
Top 5 Companies by Market Cap
Top 5 Companies by 52-Week Stock Price Change


The accompanying tables present an overview of my 48-company Global Cosmetic and Reconstructive Medicine (CRM) Index which includes companies engaged in skin care, cosmetic medicine, regenerative medicine, orthopedic repair, and joint replacements. The performance over the past year of my CRM Index compares favorably to benchmark ETFs such as HealthShares Composite (HHQ), Ortho Repair (HHP), and Skin/Wound Care (HRW). The mix of companies in this index provides exposure to medical innovators such as Cytori Therapeutics (CYTX) and its Celution System for cosmetic/regenerative medicine applications; as well as traditional ortho repair companies such as Stryker (SYK) and cosmetic medicine companies such as Allergan (AGN).


AGN:  This call was made on 10/12/08 @ $40.86
Rating:   Positive   $40.86 (10/12/08)
Closed:   12/06/2008 @ $40.22 (-1.57% in 55 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 21.10 +34.25% 378
2 18.14 +70.10% 208
3 17.66 +25.70% 55
4 13.47 +14.32% 61
5 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Allergan Inc. (AGN)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
97.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
NVO Positive -0.08% 11/22/09
DNDN Positive +0.39% 11/20/09
UNIFF N/A Positive n/a 11/19/09
BIO Positive -0.91% 11/19/09
ECTE N/A Positive n/a 11/19/09

View All >
   
Mike Havrilla previously rated AGN
Positive +5.49% New Indexes to Track Healthcare Trends and More
08/04/2009
9
Positive +47.99% FDA Calendar: Allergan's New Rx for Eyelashes
12/28/2008
9
Positive -6.59% Allergan Wants To Improve Your Eyelashes
12/06/2008
9
Positive +0.00% Bullish on AGN ...
10/11/2008
0





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch